Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion type Assertion NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_head.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion description "[These obstacles call for other strategies of metastases management, such as arresting or differentiating agents, some of which have been successfully tested by the author's group, such as antiprostaglandins, antithrombin, somatostatin, hyaluronidase, and retinoic acid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_provenance.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion evidence source_evidence_literature NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_provenance.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion SIO_000772 2403488 NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_provenance.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion wasDerivedFrom befree-20140225 NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_provenance.
- NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_assertion wasGeneratedBy ECO_0000203 NP663433.RABfuFL6He_NpNpzm23z-UVpyvVH7TTrnSpjqQ-v11xqc130_provenance.